Article
New Insights into the Implication of Epigenetic Alterations in the EMT of Triple Negative Breast Cancer
18 Apr 2019
Abstract excerpt
Breast cancer is the most common cancer and leading cause of cancer death among women worldwide, encompassing a wide heterogeneity of subtypes with different clinical features. During the last two decades, the use of targeted therapies has emerged in clinical research in order to increase treatment efficiency, improve prognosis and reduce recurrence. However, the triple negative breast cancer (TNBC) subtype...
Topics
Join the communities discussing this publication.
